NO934792L - Xantinderivater - Google Patents

Xantinderivater

Info

Publication number: NO934792L
Authority: NO; Norway
Prior art keywords: lower alkyl; independently represent; chem; represent hydrogen; hydroxy
Prior art date: 1992-12-24

Application number

NO934792A

Other languages

English (en)

Other versions

NO934792D0 (no

NO300925B1 (no

Inventor

Fumio Suzuki

Junichi Shimada

Nobuaki Koike

Hiroshi Kase

Joji Nakamura

Shizuo Shiozaki

Hiromi Nonaka

Original Assignee

Kyowa Hakko Kogyo Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-24

Filing date

1993-12-23

Publication date

1994-06-27

1993-12-23 Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk

1993-12-23 Publication of NO934792D0 publication Critical patent/NO934792D0/no

1994-06-27 Publication of NO934792L publication Critical patent/NO934792L/no

1997-08-18 Publication of NO300925B1 publication Critical patent/NO300925B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO934792A 1992-12-24 1993-12-23 Xantinderivater NO300925B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP34411692		1992-12-24

Publications (3)

Publication Number	Publication Date
NO934792D0 NO934792D0 (no)	1993-12-23
NO934792L true NO934792L (no)	1994-06-27
NO300925B1 NO300925B1 (no)	1997-08-18

Family

ID=18366763

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO934792A NO300925B1 (no)	1992-12-24	1993-12-23	Xantinderivater

Country Status (6)

Country	Link
US (1)	US5670498A (no)
EP (1)	EP0607607B1 (no)
AT (1)	ATE143019T1 (no)
CA (1)	CA2112031A1 (no)
DE (1)	DE69304883T2 (no)
NO (1)	NO300925B1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1823895A (en) *	1994-02-23	1995-09-11	Kyowa Hakko Kogyo Co. Ltd.	Xanthine derivative
ES2264210T3 (es) *	1997-09-05	2006-12-16	Kyowa Hakko Kogyo Co., Ltd.	Derivados de xantina para el tratamiento de la isquemia cerebral.
USRE47351E1 (en)	1999-06-22	2019-04-16	Gilead Sciences, Inc.	2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US6403567B1 (en) *	1999-06-22	2002-06-11	Cv Therapeutics, Inc.	N-pyrazole A2A adenosine receptor agonists
US6815446B1 (en)	1999-08-31	2004-11-09	Vanderbilt University	Selective antagonists of A2B adenosine receptors
WO2001032182A1 (fr) *	1999-10-29	2001-05-10	Kyowa Hakko Kogyo Co., Ltd	Remedes contre les troubles de l'alimentation
US20020012946A1 (en) *	2000-02-23	2002-01-31	Luiz Belardinelli	Method of identifying partial agonists of the A2A receptor
JP2005538190A (ja) *	2002-07-29	2005-12-15	シーブイ・セラピューティクス・インコーポレイテッド	心筋潅流イメージング
US8470801B2 (en)	2002-07-29	2013-06-25	Gilead Sciences, Inc.	Myocardial perfusion imaging methods and compositions
US20050020915A1 (en) *	2002-07-29	2005-01-27	Cv Therapeutics, Inc.	Myocardial perfusion imaging methods and compositions
US7148229B2 (en) *	2003-02-19	2006-12-12	Hoffman-La Roche Inc.	Sulfonamide substituted xanthine derivatives
TWI346114B (en)	2003-09-29	2011-08-01		Method for stabilization of diarylvinylene compounds
ES2532479T3 (es) *	2004-01-28	2015-03-27	Kyowa Hakko Kirin Co., Ltd.	Agentes para el tratamiento de la migraña
US7655636B2 (en)	2004-10-20	2010-02-02	Gilead Palo Alto, Inc.	Use of A2A adenosine receptor agonists
US7732595B2 (en) *	2006-02-03	2010-06-08	Gilead Palo Alto, Inc.	Process for preparing an A2A-adenosine receptor agonist and its polymorphs
CA2662278C (en) *	2006-09-01	2011-11-22	Cv Therapeutics, Inc.	Methods and compositions for increasing patient tolerability during myocardial imaging methods
US20090081120A1 (en) *	2006-09-01	2009-03-26	Cv Therapeutics, Inc.	Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
JP2011502101A (ja) *	2006-09-29	2011-01-20	ギリアード・パロ・アルト・インコーポレイテッド	肺疾患の病歴を有する患者における心筋画像化法
JP2010515081A (ja) *	2007-01-03	2010-05-06	ギリアード・パロ・アルト・インコーポレイテッド	心筋灌流画像化
US8871751B2 (en) *	2008-01-18	2014-10-28	The Board Of Trustees Of The University Of Illinois	Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer
MX2011003168A (es) *	2008-09-29	2011-05-19	Gilead Sciences Inc	Combinaciones de un agente de control de cantidad y un antagonista del receptor a-2-alfa para utilizarse en metodos de tomografia computarizada de detectores multiples.
WO2020125779A1 (en) *	2018-12-21	2020-06-25	Sunshine Lake Pharma Co., Ltd.	8-substituted styryl xanthine derivatives and uses thereof
US20220202822A1 (en) *	2019-04-24	2022-06-30	Sunshine Lake Pharma Co., Ltd.	8-substituted aryl vinyl xanthine derivatives and uses thereof
CN111018856B (zh) *	2019-12-12	2021-10-01	广东东阳光药业有限公司	8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663B (zh) *	2019-12-12	2021-10-01	广东东阳光药业有限公司	8-取代的苯乙烯基黄嘌呤衍生物及其用途
IL296215A (en) *	2020-03-10	2022-11-01	Marvel Biotechnology	Purine compounds for the treatment of diseases
CN113248505B (zh) *	2021-06-09	2021-09-21	南京安杰新生物医药有限公司	伊曲茶碱去甲基杂质的制备方法
WO2023097402A1 (en) *	2021-12-03	2023-06-08	Marvel Biotechnology	Purine compounds for treating disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4452788A (en) *	1982-04-21	1984-06-05	Warner-Lambert Company	Substituted 8-phenylxanthines
GB8510758D0 (en) *	1985-04-27	1985-06-05	Wellcome Found	Compounds
US5270316A (en) *	1989-10-20	1993-12-14	Kyowa Hakko Kogyo Co., Ltd.	Condensed purine derivatives
ES2130138T3 (es) *	1990-10-18	1999-07-01	Kyowa Hakko Kogyo Kk	Derivado de xantina.

1993
- 1993-12-21 CA CA002112031A patent/CA2112031A1/en not_active Abandoned
- 1993-12-23 AT AT93120842T patent/ATE143019T1/de not_active IP Right Cessation
- 1993-12-23 DE DE69304883T patent/DE69304883T2/de not_active Expired - Fee Related
- 1993-12-23 NO NO934792A patent/NO300925B1/no not_active IP Right Cessation
- 1993-12-23 EP EP93120842A patent/EP0607607B1/en not_active Expired - Lifetime
1995
- 1995-09-13 US US08/527,497 patent/US5670498A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE143019T1 (de)	1996-10-15
EP0607607B1 (en)	1996-09-18
US5670498A (en)	1997-09-23
EP0607607A1 (en)	1994-07-27
NO934792D0 (no)	1993-12-23
DE69304883D1 (de)	1996-10-24
CA2112031A1 (en)	1994-06-25
DE69304883T2 (de)	1997-05-15
NO300925B1 (no)	1997-08-18

Publication	Publication Date	Title
NO934792L (no)	1994-06-27	Xantinderivater
LU91210I2 (fr)	2006-11-06	Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
PL292101A1 (en)	1992-08-10	Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
DE69418704D1 (de)	1999-07-01	Anthranilsäure derivate
DE69027235D1 (de)	1996-07-11	Xanthinderivate
NO932607D0 (no)	1993-07-19	Piperidinderivater og anvendelse av disse
DE69918695D1 (de)	2004-08-19	Sauerstoffhaltige heterocyclische verbindungen
NO934536D0 (no)	1993-12-10	Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler
DK0916651T3 (da)	2003-12-01	Phenylalkylcarboxylsyrederivater
ES2123873T3 (es)	1999-01-16	Pirrolocarbazol.
NO911004D0 (no)	1991-03-13	(benzhydryloksyetylpiperidyl)alifatiske syrederivater og anvendelse derav.
SE8901060D0 (sv)	1989-03-28	New compounds
ATE125807T1 (de)	1995-08-15	Flavonderivate.
ATE134607T1 (de)	1996-03-15	Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung
ATE25519T1 (de)	1987-03-15	Benzo(f)chinolinderivate.
PT87954A (pt)	1989-06-30	Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
ATE268769T1 (de)	2004-06-15	Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date	Code	Title	Description
2005-09-12	MM1K	Lapsed by not paying the annual fees